Post-intensive Care Syndrome
Conditions
Brief summary
To identify relevant factors influencing attendance at appointments at the PICS outpatient clinic after intensive care treatment in order to derive targeted measures to increase the participation rate or send more targeted invitations.
Detailed description
This retrospective study examines which factors influence patient attendance at structured follow-up appointments after intensive care treatment in the PICS outpatient clinic at Charité. The focus is on analyzing demographic, clinical, and care-related factors that influence actual participation in follow-up care after intensive care treatment.
Interventions
None listed
Sponsors
Charite University, Berlin, Germany
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients who, between January 1, 2021, and December 31, 2025: * were invited for follow-up care by the PICS outpatient clinic of the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK) * were ≥18 years old at the time of the appointment.
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Follow-up appointment | 01.01.2021- 31.12.2025 | Participation in the first scheduled follow-up appointment at the post-intensive care syndrome (PICS) outpatient clinic (binary: attended vs. did not attend) is measured by medical record review. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cancellation of a scheduled follow-up appointment. | 01.01.2021- 31.12.2025 | Cancellation of a scheduled follow-up appointment is measured by medical record review. |
| Reasons for canceling a scheduled appointment. | 01.01.2021- 31.12.2025 | Reasons for canceling a scheduled appointment is measured by medical record review. |
| Failure to attend a scheduled follow-up appointment. | 01.01.2021- 31.12.2025 | Failure to attend a scheduled follow-up appointment is measured by medical record review. |
| Death after discharge from the intensive care unit until the first follow-up appointment. | 01.01.2021- 31.12.2025 | Death after discharge from the intensive care unit until the first follow-up appointment is measured by medical record review. |
| Death between the first and second follow-up appointments. | 01.01.2021- 31.12.2025 | Death between the first and second follow-up appointments is measured by medical record review. |
| Scheduling a second follow-up appointment after initial presentation at the outpatient clinic. | 01.01.2021- 31.12.2025 | Scheduling a second follow-up appointment after initial presentation at the outpatient clinic is measured by medical record review. |
| Attendance at the second scheduled follow-up appointment after initial presentation at the outpatient clinic. | 01.01.2021- 31.12.2025 | Attendance at the second scheduled follow-up appointment after initial presentation at the outpatient clinic is measured by medical record review. |
| Scheduling a third follow-up appointment after initial presentation at the outpatient clinic. | 01.01.2021- 31.12.2025 | Scheduling a third follow-up appointment after initial presentation at the outpatient clinic is is measured by medical record review. |
| Attendance at the third scheduled follow-up appointment after initial presentation at the outpatient clinic. | 01.01.2021- 31.12.2025 | Attendance at the third scheduled follow-up appointment after initial presentation at the outpatient clinic is measured by medical record review. |
Countries
Germany
Contacts
CONTACTClaudia Spies, MD, Prof.
STUDY_DIRECTORClaudia Spies, MD, Prof.
Charite University, Berlin, Germany
Outcome results
None listed